Revision history of "STUDY OF THE MECHANISMS OF ACTION OF CELYVIR THERAPY IN CHILDHOOD TUMORS: TOWARDS THE OPTIMISATION OF CLINICAL OUTCOMES" (Q3154212)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

23 March 2024

20 December 2023

12 June 2023

10 June 2023

4 August 2022

  • curprev 08:2908:29, 4 August 2022DG Regio talk contribs 64,802 bytes +43,777 Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv, nl, fr, de, it, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv,

16 January 2022

17 December 2021

9 December 2021

4 December 2021

12 October 2021

  • curprev 15:3715:37, 12 October 2021DG Regio talk contribs 11,899 bytes +1,964 Created claim: summary (P836): Our research team has developed a new treatment strategy for refractory childhood solid tumors: Celyvir, autologous mesenchymal cells infected with an oncolytic adenovirus. In this project we aim to improve the results of Celyvir therapy, through a greater understanding of the immune response that is associated with clinical response in patients, both antiadenoviral and antitumoral. For this we will validate a murine model of spontaneous neurobl...
  • curprev 15:3715:37, 12 October 2021DG Regio talk contribs 9,935 bytes −1,964 Removed claim: summary (P836): Our research team has developed a new treatment strategy for refractory childhood solid tumors: Celyvir, autologous mesenchymal cells infected with an oncolytic adenovirus. In this project we aim to improve the results of Celyvir therapy, through a greater understanding of the immune response that is associated with clinical response in patients, both antiadenoviral and antitumoral. For this we will validate a murine model of spontaneous neuro...
  • curprev 15:3415:34, 12 October 2021DG Regio talk contribs 11,899 bytes +179 Changed label, description and/or aliases in en: translated_label
  • curprev 15:3415:34, 12 October 2021DG Regio talk contribs 11,720 bytes +1,964 Created claim: summary (P836): Our research team has developed a new treatment strategy for refractory childhood solid tumors: Celyvir, autologous mesenchymal cells infected with an oncolytic adenovirus. In this project we aim to improve the results of Celyvir therapy, through a greater understanding of the immune response that is associated with clinical response in patients, both antiadenoviral and antitumoral. For this we will validate a murine model of spontaneous neurobl...

10 October 2021

9 October 2021

8 October 2021